A

AbbVie

Global biopharmaceutical company developing medicines

Director CMC Product Development

Bioprocess & BiomanufacturingPosted on Nov 5
Full-timeNorth Chicago, IL, USAIn-person

About the Job

Requirements

  • A Bachelor's degree with at least 12 years of relevant industry experience, a Master's degree with at least 10 years, or a PhD with at least 8 years of relevant experience.
  • At least 3 years of experience as a CMC team leader or in a relevant role in a related CMC function.
  • Significant pharmaceutical development experience, strong interdisciplinary CMC expertise, and understanding of drug development, global regulatory and quality requirements, and CMC strategies across development stages.
  • Ability to lead and influence highly matrixed, cross-functional teams, build alignment without relying on formal authority, and establish trust and credibility with team members, stakeholders, and senior leaders.
  • Written and verbal communication skills, including the ability to translate complex scientific and technical information into clear strategic choices and recommendations for diverse audiences.
  • Leadership, interpersonal, negotiation, and influencing skills, sound scientific and business judgment, and ability to make timely decisions.
  • Strategic thinking, adaptability, learning agility, and ability to navigate ambiguity, with curiosity and willingness to expand into new scientific areas, technologies, and modalities.

Responsibilities

  • Serve as the CMC leader, integrator, and spokesperson on the Asset Strategy Team (AST), connecting CMC strategy with the overarching asset strategy and ensuring clear, timely, and effective communication across the AST, CMC functions, and key stakeholders.
  • Lead and inspire highly matrixed, cross-functional Product Presentation and Device Strategy teams (PPDST) and CMC teams, creating clarity of purpose, aligning diverse perspectives, facilitating effective decision-making, and building a collaborative and accountable team culture.
  • Develop, communicate, and drive the integrated CMC strategy and development plan for complex assets, translating scientific and technical considerations into strategic choices, priorities, timelines, risks, and recommendations for teams and senior leaders.
  • Communicate complex CMC topics as clear messages and recommendations, proactively surface risks and opportunities, and enable informed decisions by asset teams, senior leaders, and governance bodies.
  • Connect teams across the organization and development lifecycle, from late discovery through clinical development and technology transfer to commercial manufacturing; build relationships and alignment across CMC, Clinical, Regulatory, Quality, Operations, Preclinical Safety, ADME, Commercial, external partners, and other stakeholders; mentor and develop CMC leaders and team members.
  • Build trust and credibility with team members, stakeholders, and leadership through scientific credibility, sound judgment, and influence; align priorities, resources, and timelines across functions; navigate ambiguity, resolve issues, foster open dialogue, and build alignment around decisions that advance the asset.
  • Shape team culture by promoting scientific excellence, inclusion, collaboration, candid dialogue, entrepreneurial thinking, accountability, and shared ownership for the success of the asset and broader portfolio.
  • Lead a portfolio of programs across modalities that may include small molecules, biologics, antibody-drug conjugates, cell and gene therapies, toxins, devices, and implants.

Desired Qualifications

  • Experience developing biologics and/or other complex modalities, including antibody-drug conjugates, cell and gene therapies, and combination or device products.
  • Experience with strategic collaborations, due diligence, external innovation, or integrating externally developed assets or technologies into an internal development pipeline.
  • Ability and interest in learning new modalities and scientific areas and applying existing CMC and development expertise to new technologies and increasingly complex programs.

About the Company

AbbVie

Global biopharmaceutical company developing medicines

AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.

Company size
10,001+
Company stage
IPO
Headquarters
North Chicago, IL
Founded
1888

Recently Posted Jobs

Explore more opportunities at AbbVie

See more jobs